Skip to main content
SpringerLink
Log in
Book cover

Purine and Pyrimidine Metabolism in Man IX

  • Book
  • © 1998

Overview

Editors:
  1. Andrea Griesmacher

    1. Emperor Franz Joseph Hospital, Vienna, Austria

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Mathias M. Müller

    1. Emperor Franz Joseph Hospital, Vienna, Austria

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Peter Chiba

    1. University of Vienna, Vienna, Austria

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 431)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (166 chapters)

  1. Front Matter

    Pages i-xxiii
    Download chapter PDF

  2. Gout: Clinics and Treatment

    1. Front Matter

      Pages xxv-xxv
      Download chapter PDF

    2. Gout New Questions for an Ancient Disease

      • Juan G. Puig, Felicitas A. Mateos, Teresa Sancho, Rosa J. Torres, Antonio Buño, Eugenio de Miguel et al.
      Pages 1-5

    3. Efficacy of Allopurinol in Ameliorating the Progressive Renal Disease in Familial Juvenile Hyperuricaemic Nephropathy (FJHN)

      • M. B. McBride, H. A. Simmonds, C. S. Ogg, J. S. Cameron, S. Rigden, L. Rees et al.
      Pages 7-11

    4. Optimal Range of Serum Urate Concentrations to Minimize Risk of Gouty Attacks During Anti-Hyperuricemic Treatment

      • Hisashi Yamanaka, Riko Togashi, Masayuki Hakoda, Chihiro Terai, Sadao Kashiwazaki, Takashi Dan et al.
      Pages 13-18

    5. How Should we Treat Tophaceous Gout in Patients with Allopurinol Hypersensitivity?

      • R. Grahame, H. A. Simmonds, M. B. McBride, F. P. Marsh
      Pages 19-23

    6. The Spectrum of HGPRT Deficiency

      • Juan G. Puig, Rosa J. Torres, Felicitas A. Mateos, Joaquín Arcas, Antonio Buño, Ignacio Pascual-Castroviejo
      Pages 25-29

    7. Plasma Uridine as well as Uric Acid is Elevated Following Fructose Loading

      • P. M. Davies, H. A. Simmonds, B. Singer, T. G. Mant, E. M. Allen, A. B. Vassos et al.
      Pages 31-35

    8. Inverse Relationship Between Serum Triglyceride Levels and Fractional Urate Excretion

      • C. P. Quaratino, M. Mellozzi, G. Tamburrano, A. Giacomello
      Pages 37-40

    9. Microanalysis of Pathological Crystals and Urinary Calculi

      • Kiyoko Kaneko, Shin Fujimori, Naoyuki Kamatani, Hisashi Yamanaka, Noriko Yamaoka, Ieo Akaoka
      Pages 41-45

    10. Zonal Distribution of Allopurinol-Oxidizing Enzymes in Rat Liver

      • Yuji Moriwaki, Tetsuya Yamamoto, Jun-ichi Yamakita, Sumio Takahashi, Zenta Tsutsumi, Kazuya Higashino
      Pages 47-50

    11. Severe Debilitating Polyarticular Gout and Terminal Renal Failure in an Allopurinol ‘Non-Responder’

      • S. Reiter, R. Engelleiter, H. Proske, A. Müller, F. J. van der Woude, J. A. Duley et al.
      Pages 51-55

    12. Decreased Serum Concentrations of 1,25(OH)2-Vitamin D3 in Patients with Gout

      • Sumio Takahashi, Tetsuya Yamamoto, Yuji Moriwaki, Zenta Tsutsumi, Jun-ichi Yamakita, Kazuya Higashino
      Pages 57-60

    13. Lipoproteins in Patients with Isolated Hyperuricemia

      • F. J. Tinahones, F. Vazquez, F. J. Soriguer, E. Collantes
      Pages 61-67

    14. Atherogenic Risk Factors in Patients with Gout

      • Zenta Tsutsumi, Tetsuya Yamamoto, Sumio Takahashi, Yuji Moriwaki, Jun-ichi Yamakita, Yumiko Nasako et al.
      Pages 69-72

  3. Adenosine Workshop

    1. Cardiovascular Actions of Adenosine

      • B. F. Becker, S. Zahler, C. Kupatt, C. Seligmann, B. Heindl, C. Kowalski
      Pages 73-78

    2. Mast Cell Adenosine Receptor Characteristics and Signaling

      • Diana L. Marquardt
      Pages 79-82

    3. Purine and Pyrimidine Nucleoside Content of the Neuronal Extracellular Space in Rat

      • Á. Dobolyi, A. Reichart, T. Szikra, G. Juhász
      Pages 83-87

    4. Effect of FMLP Stimulation on [3H]-NECA Binding to Adenosine Receptors in Neutrophils Membranes

      • C. Martini, L. Trincavelli, M. Fiorini, M. Nardi, A. Lucacchini, L. Bazzichi
      Pages 89-94

    5. Effects of Nucleoside Transport Inhibitors and Adenine/Ribose on ATP Concentration and Adenosine Production in Cardiac Myocytes

      • Kameljit K. Kalsi, Ryszard T. Smolenski, Magdi H. Yacoub
      Pages 95-98
Back to top

Keywords

About this book

th th This volume comprizes articles presented at the joint IX International and 6 Euro­ pean Symposium on Purine and Pyrimidine Metabolism in Man held in Gmunden, Austria, June 1 through 7, 1997. Since the first of this series of meetings was held in Israel in 1973, conventions were organized every three years in different parts of the world including the USA, Japan, and Europe. The different aspects of purine and pyrimidine metabolism bring together re­ searchers working in molecular genetics, biochemical pharmacology, biochemistry, devel­ opmental biology, immunology, epidemiology and the clinics. Oriented research in the field has been seminal for the development of potent anticancer and antiviral drugs. As the number of genes which are cloned, grows, the understanding of metabolism is increas­ ingly enlarged and might provide leads to further improve therapeutic concepts and to bet­ ter understand mechanisms responsible for the development of resistance against these drugs. In certain diseases purine and pyrimidine analogs represent not only the drugs of choice but in fact are the sole therapeutic alternative at present. The field has also taken an early lead in attempting to correct inborn errors of purine and pyrimidine metabolism by gene therapy. The organization of this meeting involved a large number of people who dedicated their time in an effort to make this symposium a success. We thank the Abstract Review Committee, the International Advisory Board and in particular the Symposium Secretariat for doing a wonderful job.

Editors and Affiliations

  • Emperor Franz Joseph Hospital, Vienna, Austria

    Andrea Griesmacher, Mathias M. Müller

  • University of Vienna, Vienna, Austria

    Peter Chiba

Bibliographic Information

  • Book Title: Purine and Pyrimidine Metabolism in Man IX

  • Editors: Andrea Griesmacher, Mathias M. Müller, Peter Chiba

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4615-5381-6

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1998

  • Hardcover ISBN: 978-0-306-45778-4Due: 30 April 1998

  • Softcover ISBN: 978-1-4613-7456-5Published: 05 November 2012

  • eBook ISBN: 978-1-4615-5381-6Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XXV, 866

  • Topics: Biochemistry, general, Pharmacology/Toxicology, Animal Anatomy / Morphology / Histology

Publish with us

Policies and ethics

Back to top

Search

Navigation